P174 Treg Cell and Human Intestinal Myofibroblast-Derived Amphiregulin induced by TGF-β Promotes Colitis-Associated Intestinal Fibrosis

L Wang,H Zhang,X Zhao
DOI: https://doi.org/10.1093/ecco-jcc/jjad212.0304
2024-01-01
Journal of Crohn's and Colitis
Abstract:Abstract Background Intestinal fibrosis is one of the most threatening complications of Crohn’s disease (CD). Intestinal fibrosis is usually the result of chronic inflammation, and T cell response is the main driver of intestinal inflammation. At present, there are few researches on the mechanism of Treg cells in intestinal fibrosis, and the role of Treg-derived Areg in intestinal fibrosis has not been studied. Methods AREG and TGF-β expression was assessed in patients with CD with or without intestinal fibrosis by quantitative reverse-transcriptase polymerase chain reaction (qRT-PCR). In this study, dextran sulfate sodium (DSS)-induced chronic colitis model in wild-type (WT) and Areg-/- mice and T-cell transfer model with WT and Areg-/- Treg cells were used. CD4+ T cell expression of AREG induced by Treg cell differentiation-related cytokines and self-secreted cytokines was determined by Western blotting. Human intestinal myofibroblasts expression of AREG induced by different cytokines was determined by qRT-PCR. The effect of AREG on proliferation/migration in human intestinal myofibroblasts was determined. Results AREG and TGF-β expression was increased in fibrotic sites compared with nonfibrotic sites from patients with CD. Although DSS-induced more severe colitis in Areg-/- mice, which developed less severe intestinal fibrosis compared with WT mice on DSS insults. Transfer of Areg-/- Treg cells induced less severe fibrosis in Rag-/- mice compared with WT Treg cells. TGF-β promoted AREG expression in Treg cells by activating Smad3. In addition, TGF-β promoted the AREG expression in Treg cells in a time and dose dependent manner. TGF-β also promoted the AREG expression in human intestinal myofibroblastss from CD patients with fibrosis. AREG promoted human intestinal myofibroblast proliferation and motility. Conclusion These findings revealed that Treg and human intestinal myofibroblast-derived AREG induced by TGF-β promotes intestinal fibrotic responses in experimental colitis and human patients with CD.
gastroenterology & hepatology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the mechanism of action of Amphiregulin (Areg) induced by Transforming Growth Factor - β (TGF - β) derived from regulatory T cells (Treg cells) and human intestinal myofibroblasts in intestinal fibrosis associated with Crohn's disease (CD). Specifically, the study aims to clarify the function of Treg cells and the Areg secreted by them in the process of intestinal fibrosis, and how TGF - β affects this process. The research background indicates that intestinal fibrosis is one of the most serious complications of Crohn's disease, which is usually caused by chronic inflammation, and the T - cell response is the main driving factor for intestinal inflammation. However, at present, there are few studies on the mechanism of Treg cells in intestinal fibrosis, especially the role of Areg derived from Treg cells in intestinal fibrosis has not been fully studied. By using the DSS - induced chronic colitis mouse model and the T - cell transfer model, and by detecting the influence of different cytokines on Areg expression, the study found that TGF - β can promote the expression of Areg in Treg cells and human intestinal myofibroblasts, and this expression is time - and dose - dependent. In addition, Areg can promote the proliferation and migration of human intestinal myofibroblasts, which may exacerbate the process of intestinal fibrosis. In summary, this study reveals the important role of Areg induced by TGF - β derived from Treg cells and human intestinal myofibroblasts in the intestinal fibrosis response in experimental colitis and Crohn's disease patients. This finding provides a new perspective for understanding the pathophysiology of Crohn's disease - related intestinal fibrosis and may provide a theoretical basis for the development of new treatment strategies.